Analisis Interaksi Obat Secara Farmakokinetik dan Farmakodinamik Terhadap Pasien Nefropati Diabetik di Rumah Sakit X Kota Jambi Tahun 2022

Zahratul Farah, Deny Sutrisno, Aisa Dinda Mitra

Abstract


Diabetic nephropathy (ND) is a complication of diabetes in the kidney. Nephropathy, or kidney disease, is the leading cause of death and disability in diabetes. The first clinical manifestation of diabetic nephropathy is microalbuminuria. If a patient is diagnosed with microalbuminuria, the development of end-stage renal and cardiovascular disease can be prevented by controlling blood pressure, glucose, and lipids. This study aimed to determine pharmacokinetic and pharmacodynamic drug interactions, determine drug interactions and severity in patients, determine the relationship between age and drug severity and gender relationship with drug severity in patients with diabetic nephropathy at X Hospital Jambi City in 2022. The method used in this research is descriptive method. The data collected in this study came from the medical records of diabetic nephropathy patients at X Hospital Jambi City in 2022. The total population in this study was 67 patients with a total sample of 46 patients. The results showed that the highest prevalence in the sample was female (56.52%), elderly patients aged 46-55 years (47.83%), drugs that interact with lantus ˃˂ novorapid (8.43%), patients experiencing drug interactions (71.74%), pharmacodynamic interactions (92.77%), pharmacokinetic interactions (4.82%), minor (10.84%), moderate (78.31%), and major severity (10.84%). The conclusions drawn from this study were based on the interaction mechanism, namely there were 6 cases (7.23%) of pharmacokinetic interactions and 77 cases of pharmacodynamic interactions (92.77%). Based on interactions with 9 cases of minor severity (10.84%), 65 cases of moderate severity (78.31%), and 9 cases of major severity (10.84%). And there is no relationship between the severity of the drug and age and gender.


Keywords


diabetic nephropathy; drug interactions

Full Text:

PDF

References


Amelia Agustin, O., & Fitrianingsih. 2020. Kajian Interaksi Obat Berdasarkan Kategori Signifikansi Klinis Terhadap Pola Peresepan Pasien Rawat Jalan Di Apotek X Jambi. E-SEHAD, 1, 1–10.

Auliafendri, N., & Darmiyani. 2022. Evaluasi Interaksi Obat Jantung Koroner Pada Pasien Rawat Inap Di Rumah Sakit Umum Imelda Pekerja Indonesia Medan. JIFI (Jurnal Ilmiah Farmasi Imelda), 5(2), 43–50. https://doi.org/10.52943/jifarmasi.v5i2.775

Awad, N., Langi, Y. A., & Pandelaki, K. 2013. Gambaran Faktor Resiko Pasien Diabetes Melitus Tipe Ii Di Poliklinik Endokrin Bagian/Smf Fk-Unsrat Rsu Prof. Dr. R.D Kandou Manado Periode Mei 2011-Oktober 2011. Jurnal E-Biomedik (EBM), 1, 45–49.

Fanani Akhmad. 2020. Hubungan Faktor Risiko dengan Kejadian Diabetes Mellitus. Jurnal Keperawatan, 12, 371–378.

Fernanda, N., Saputri, G. A. R., & Ulfa, A. M. 2022. Penggunaan Insulin dan Gliquidon pada Pasien Komplikasi Nefropati Diabetik Salah Satu Rumah Sakit di Lampung Tahun 2020. Journal of Islamic Medicine, 6(1), 60–67. https://doi.org/10.18860/jim.v6i1.13579

Hamaty, M. 2011. Insulin treatment for type 2 diabetes: When to start, which to use. Cleveland Clinic Journal of Medicine, 78(5), 332–342. https://doi.org/10.3949/ccjm.78a.10051

Harie, S. E., Eva Decroli, & Afriwardi. 2018. Faktor Resiko Pasien Nefropati Diabetik yang Dirawat di Bagian Penyakit Dalam RSUP DR. M. Djamil Padang. Jurnal Kesehatan Andalas.

Hidayah, K., Kundarto, W., & Farida, Y. 2016. Patient Center Care Dalam Penanganan Diabetes Melitus Obese Geriatri Secara Koprehensif Identifikasi Potensi Interaksi Obat pada Peresepan Obat Pasien Hipertensi dengan Diabetes Mellitus.

Kardela, W., Abdillah, R., Handicka, G., Tinggi, S., Farmasi, I., & Padang, S. 2019. Rasionalitas Penggunaan Obat Diabetes Mellitus Tipe 2 komplikasi Nefropati di Rumah Sakit Umum Pusat dr. M.Djamil Padang. In Jurnal Farmasi Higea, 11(2).

Kardela, W., Bellatasie, R., & Rustam, E. 2022. Evaluasi Masalah Terkait Obat pada Pasien Diabetes Melitus Tipe II dengan Gagal Ginjal Kronik di Rawatan Inap RSUP DR. M. Djamil Padang. In Jurnal Farmasi Higea, 14(1).

Kusdiyah, E., Jufri Makmur, M., & Aras, R. B. P. 2020,. Karakteristik Faktor-Faktor Risiko Terjadinya Komplikasi Kronik Nefropati Diabetik dan atau Penyakit Pembuluh Darah Perifer Pada Penderita Diabetes Mellitus di Rsud Raden Mattaher Tahun 2018.

Nurlaelah, I., Mukaddas, A., & Faustine, I. 2015. Kajian Interaksi Obat Pada Pengobatan Diabetes Melitus (DM) Dengan Hipertensi Di Instalasi Rawat Jalan Rsud Undata Periode Maret-Juni Tahun 2014 Study Of Drug Interaction In Treatment Of Diabetes Melitus With Hypertension In Outpatient Installation In Rsud Undata Palu Period March-June 2014. Galenika Journal of Pharmacy, 35.

Pralisa, K., Dewi, D. A. K., & Ilmiawan, M. I. 2021. Gambaran etiologi penyakit ginjal kronik stadium V pada pasien rawat inap di RSUD Dokter Soedarso Pontianak tahun 2017-2018. Jurnal Cerebellum, 6(3), 59. https://doi.org/10.26418/jc.v6i3.45308

Puspitasari, A. W., & Angeline, L. 2019. Analisis Potensi Interaksi Obat Golongan Antidepresan pada Pasien Skizofrenia di Rumah Sakit Jiwa Dr. Soeharto Heerdjan Tahun 2016 Analysis of Potential Antidepressant Drug Interactions in Schizophrenic Patients at Dr. Soeharto Heerdjan 2016. Pharmaceutical Sciences and Research, 6(1), 13–20.

Riskesdas. 2018. Badan Penelitian dan Pengembangan Kesehatan Dasar Departemen Kesehatan Republik Indonesia.

Stevani, H., Sulfiana, S., & Farid, A. M. 2019. Identifikasi Drug Related Problems pada Pasien Diabetes Melitus Tipe II dengan Komplikasi Hipertensi Di Instalasi Rawat Inap RSUD Labuang Baji Kota Makassar Periode Januari-Juni 2016. Media Farmasi.

Swastika, M. R. D. 2007. Evaluasi Pengobataan Pada Kasus Diabetes Mellitus Dengan Komplikasi Nefropati Diabetik Di Instalasi Rawat Inap Rumah Sakit Bethesda Yogyakarta Periode Tahun 2005.

Utami, P. R., & Fuad, K. 2018. Gambaran Kadar Hemoglobin pada Penderita Diabetes Melitus Komplikasi Ginjal. Perintis’s Health Journal, 5.

Yulianti, E. 2009. Mikroalbuminuria pada Penderita Diabetes Mellitus Tipe 2 Hipertensif. Jurnal Penelitian Saintek, 14.




DOI: http://dx.doi.org/10.33087/jiubj.v24i1.4688

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

ADRESS JOURNAL

JURNAL ILMIAH UNIVERSITAS BATANGHARI JAMBI (JIUBJ)
Published by Lembaga Penelitian dan Pengabdian kepada Masyarakat
Adress: Jl.Slamet Ryadi, Broni-Jambi, Kec.Telanaipura, Kodepos: 36122, email: jiubj.unbari@gmail.com, Phone: 0741-670700

Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.